VJHemOnc is committed to improving our service to you

VJVirtual | AML: the cytogenetic risk score

VJHemOnc is committed to improving our service to you

Arnon Nagler

Arnon Nagler, MD, MSc, Sheba Medical Center, Tel-Aviv, Israel, discusses the cytogenetic abnormalities seen in acute myeloid leukemia (AML), the development of a cytogenetic risk score and how this is important to allogeneic stem cell transplantation (ASCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter